Drugmaker settles EpiPen antitrust litigation for $264M
This post was originally published on this siteU.S. health care company Viatris, formerly known as Myland, on Monday announced it had agreed to pay $264 million to settle a class-action lawsuit over the pricing of EpiPens.The agreement, which must still be approved by the court, would seek…
Democrats have a plan to cap insulin at $35 a month. Republicans won’t say if they’ll block it.
Democrats have a plan to cap insulin at $35 a month. Republicans won’t say if they’ll block it.
AstraZeneca to take profits from Covid vaccine
This post was originally published on this siteThe drugs giant signs new deals, but poorer countries will continue to get the vaccine at cost price.
